Cointime

Sarissa Biomedical

company

About

Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines.

  • 1 - 10

Highlights

Total Funding Amount
£1.20M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Angel
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2002
Number Of Employee
1 - 10
Operating Status
Active

Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity / disorders and has a product design platform that offers exquisite sensitivity, coupled with a broad linear range and high levels of accuracy and reproducibility. These biosensors are designed for in vitro and in vivo studies for research and diagnostic applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
£1.20M
Sarissa Biomedical has raised a total of £1.20M in funding over 2 rounds. Their latest funding was raised on May 28, 2020 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 28, 2020 Series Unknown £1.20M 2 — — Detail
Dec 1, 2010 Angel — 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
Sarissa Biomedical is funded by 3 investors. The Wood Family and Mercia’s EIS funds are the most recent investors.
Investor Name Lead Investor Funding Round
The Wood Family — Series Unknown
Mercia’s EIS funds — Series Unknown
Mercia Fund Managers — Angel
Cointime
İçerikler
Şirket.